Full activation of T cells requires that the main signal is recognized by the T‐cell receptor and antigen peptide/major histocompatibility complex, and the auxiliary signals driven by co‐stimulatory molecules, such as CD80 and CD86, which are present on tumor or antigen‐presenting cells (APCs). This evidence concerns the gene CD80 and neoplasm.